跳至主要内容
临床试验/NCT03164798
NCT03164798已完成不适用

Serum BDNF Role as a Biomarker for Stroke Rehabilitation

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Serum BDNF

研究概览

简要总结

This study aims to develop the quantitative biomarker to establish the individualized strategy in stroke rehabilitation. Brain-derived neurotrophic factor (BDNF) acts on certain neurons of the central nervous system (CNS) helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. BDNF in CNS can be assessed by analysing serum BDNF. The final objective of this study is to demonstrate a role of biomarker of BDNF in stroke rehabilitation to establish the individualized strategy.

详细描述

Serum BDNF, proBDNF and MMP-9 in all participants will be measured before and after the comprehensive inpatient rehabilitation during subacute stroke phase. At 3 months after stroke onset, serum BDNF, proBDNF and MMP-9 will also be measured.

In addition, motor impairment with Fugl-Meyer assessement will be assessed at same time points with serum analysis.

We will compare potential serum biomarkers with motor impairment in stroke patients

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • unilateral stroke patients
  • admission to the rehabilitation department before 1 month after stroke onset
  • mild to severe motor impairment at time of transferring to the rehabilitation department

排除标准

  • Progressive or unstable stroke
  • Pre-existing and active major neurological disease
  • Pre-existing and active major psychiatric disease
  • Advanced liver, kidney, cardiac, or pulmonary disease
  • A terminal medical diagnosis consistent with survival < 1 year)
  • Pregnant or lactating woman

结局指标

主要结局

Serum BDNF

时间窗: At 2 weeks after the comprehensive inpatient rehabilitation

serum BDNF level

次要结局

  • MMP-9(At 2 weeks after the comprehensive inpatient rehabilitation)
  • Serum proBDNF(At 2 weeks after the comprehensive inpatient rehabilitation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won Hyuk Chang

Associate Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验